NLA team to take 1st place in  «BioMAH» conference in  Rome

October 25, 2016

Researchers from the National Laboratory Astana successfully performed during «Biomaterials for Healthcare: Tissue and Genetic Engineering and the Role of Nanotechnology» (BioMAH)  international scientific conference in the heart of Italy, where scientists and biotechnologists from more than twenty-five countries around the world  came together.

This conference covered various issues regarding innovative biomaterials and approaches for tissue regeneration. Its scope was to create a platform for exchanging the latest research results and sharing advanced methods between the scientific community and industries. Participants from various countries attended the conference, among them leading researchers in the biomaterials science field, manufacturers from orthopaedic surgery, neurosurgery, dentistry and pharmaceuticals, engineers, biologists, surgeons, physicians, dentists and other clinical personnel, closely connected with the application of biomaterials.

During the conference NLA’s team from the Laboratory of Bioengineering and Regenerative Medicine presented the results of several research projects in the field of regenerative medicine and tissue bioengineering. The results of the scientific and technological project  such as "Mesenchymal stem cells coated with synthetic bone-targeted polymer as a new approach for managing of osteoporotic bone fracture regeneration" presented by Julia Safarova, NLA junior researcher was highly appreciated by the expert commission of BioMAH- 2016. The project won the first prize in "The best oral young researcher's presentation» nomination.

According to Sholpan  Askarova, head of  Laboratory of  Bioengineering and Regenerative Medicine, NLA given that the osteoporosis is spread  vastly around the world, and due to high level of disability of osteoporosis-related fractures, the scientific group of the laboratory has been developed a method of stimulating the regenerative osteogenesis, including the injection implantation  combined a mesenchymal stem cells coated with synthetic bone-targeted polymer in the zone of osteoporotic bone fracture of the experimental animal model.

This methodology will improve the bone tissue regeneration and can serve as a basis for the development of  the promising cell engineering approaches in the treatment of osteoporosis-related fractures, which will contribute to improving the quality of life and reduce the disability of patients in this category.